South Africa’s trial shows promise for a drug-resistant TB regimen. Eyewitness News reports that almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday. The findings, which have yet to be published, were presented this week at the annual Conference on Retroviruses and Opportunistic Infections.